Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2037

Conditions

Solid Tumor, Adult

Interventions

BIOLOGICAL

Neoantigen mRNA Vaccine

Deliver neoantigen mRNA vaccine into patients for anti-ancer therapy.

Trial Locations (1)

RECRUITING

Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors

lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER